Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its participation ...

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned ...

Building the world's largest biobank with data from global populations to accelerate biomarker and drug discovery and ...

Intelligent Bio Solutions (INBS) announced that the Company has been granted a patent in the United States relating to its Intelligent ...

A passport becomes invalid if it is damaged beyond repair, so it is important to keep it in order. Here are examples of what ...

Tankersley was pitted against Brad Sample in a battle round on NBC's "The Voice." They are joining forces for an inaugural ...

On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...

INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030Major Spanish accounts currently require ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.